Matsunaga Kate, Rajagopalan Archeta, Nallasamy Sudha, Nguyen Angeline, de Castro-Abeger Alexander, Borchert Mark S, Chang Melinda Y
Department of Ophthalmology, University of Southern California, Los Angeles, California.
Department of Ophthalmology, University of Southern California, Los Angeles, California; Division of Ophthalmology, Children's Hospital Los Angeles, Los Angeles, California.
Ophthalmology. 2025 Mar;132(3):335-342. doi: 10.1016/j.ophtha.2024.09.021. Epub 2024 Sep 23.
To identify clinical and sociodemographic factors associated with disparities in amblyopia treatment outcomes.
Retrospective chart review.
Children ≤ 8 years of age diagnosed and treated for unilateral refractive or strabismic amblyopia at our institution from 2012 to 2022.
Children with amblyopia were categorized by outcome: resolved amblyopia (< 0.2 logarithm of the minimum angle of resolution [logMAR] interocular difference [IOD] in visual acuity [VA] or no fixation preference in nonverbal patients) or persistent amblyopia. Demographic and clinical data were recorded from the medical record. Zip codes were used to calculate Childhood Opportunity Index (COI) scores, estimated annual household income, and distance to hospital.
Sociodemographic and clinical factors were compared between children with resolved and persistent amblyopia. Factors significant at P < 0.10 on univariate analysis were included in a multivariable regression model.
A total of 168 patients met inclusion criteria, and 131 patients (78%) had resolved amblyopia. Demographic factors associated with resolution of amblyopia were younger age at diagnosis (3.3 ± 1.7 years vs. 4.5 ± 1.9 years; P = 0.0009), English as the primary language (79.4% vs. 62.2%; P = 0.04), higher estimated annual income ($83 315.93 ± $29 276.64 vs. $71 623.00 ± $26 842.56; P = 0.03), higher COI scores (50.9 ± 27.3 vs. 40.0 ± 26.4; P = 0.03), and living farther from our institution (28.6 ± 37.6 miles vs. 14.9 ± 12.7 miles; P = 0.003). Patients with resolved amblyopia also had higher rates of treatment compliance (83.2% ± 25.0% vs. 75.6% ± 24.4%; P = 0.009) and shorter delays in follow-up (40.1 ± 76.8 days vs. 61.1 ± 90.4 days; P = 0.02). Amblyopia persistence was borderline associated with governmental insurance and higher presenting IOD in VA (both P = 0.06). On multivariate analysis, only younger age at amblyopia diagnosis (P = 0.0010) remained significantly associated with amblyopia resolution.
Our findings suggest that disparities in amblyopia outcomes are related to differences in age at diagnosis. Interventions to lower the age at which amblyopia is diagnosed, such as programs to improve vision screening rates and access to pediatric eye care in at-risk groups, may directly address inequities in rates of amblyopia resolution.
FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
确定与弱视治疗结果差异相关的临床和社会人口学因素。
回顾性病历审查。
2012年至2022年在我们机构诊断并接受单侧屈光性或斜视性弱视治疗的8岁及以下儿童。
弱视儿童按结果分类:弱视治愈(视力[VA]的最小分辨角对数[logMAR]眼间差异[IOD]<0.2或非语言患者无注视偏好)或弱视持续存在。从病历中记录人口统计学和临床数据。使用邮政编码计算儿童机会指数(COI)得分、估计的家庭年收入和到医院的距离。
比较弱视治愈和持续存在的儿童的社会人口学和临床因素。单变量分析中P<0.10有显著意义的因素纳入多变量回归模型。
共有168例患者符合纳入标准,131例患者(78%)弱视治愈。与弱视治愈相关的人口统计学因素包括诊断时年龄较小(3.3±1.7岁对4.5±1.9岁;P = 0.0009)、以英语为主要语言(79.4%对62.2%;P = 0.04)、估计年收入较高(83315.93±29276.64美元对71623.00±26842.56美元;P = 0.03)、COI得分较高(50.9±27.3对40.0±26.4;P = 0.03)以及居住距离我们机构较远(28.6±37.6英里对14.9±12.7英里;P = 0.003)。弱视治愈的患者治疗依从率也较高(83.2%±25.0%对75.6%±24.4%;P = 0.009)且随访延迟较短(40.1±76.8天对61.1±90.4天;P = 0.02)。弱视持续存在与政府保险和VA中较高的初始IOD临界相关(均P = 0.06)。多变量分析中,仅弱视诊断时年龄较小(P = 0.0010)仍与弱视治愈显著相关。
我们的研究结果表明,弱视治疗结果的差异与诊断年龄的差异有关。降低弱视诊断年龄的干预措施,如提高视力筛查率和改善高危人群获得儿科眼科护理的项目,可能直接解决弱视治愈率的不平等问题。
专有或商业披露信息可在参考文献之后找到。